PAX8 rs62158206: Genetics and Sleep Duration
The genetic variant rs62158206 is a single-nucleotide polymorphism located on chromosome 2 near the PAX8 gene. Large-scale genome-wide association studies have identified it as a prominent locus linked to habitual sleep duration and tendencies toward longer sleep. Carrying the variant allele is associated with subtle differences in nightly sleep time across broad human populations.
What each genotype means
Typical sleep duration profile
You carry two copies of the common C reference allele near the PAX8 locus. Research indicates this genotype is not linked to increased odds of extended or long sleep duration, representing an average genetic background for nightly sleep patterns. Sleep length remains heavily influenced by lifestyle habits, circadian routines, and overall health.
Carried by approximately 70% to 75% of individuals of European descent and represents the majority genotype worldwide.
Modestly increased sleep duration
You carry one copy of the T effect allele associated with slightly longer habitual sleep duration in large biobank meta-analyses. While individuals carrying this allele show a statistical tendency toward longer sleep times, the individual genetic effect size is small and varies across different ancestral backgrounds. This result reflects a subtle population-level tendency rather than a clinical diagnosis of any sleep disorder.
Carried by roughly 25% of individuals of European ancestry, with lower prevalence observed in East Asian populations.
Tendency toward longer sleep
You carry two copies of the T allele near the PAX8 locus, which genome-wide association studies link to a statistical tendency toward longer sleep duration. Current scientific findings suggest an additive effect on habitual sleep duration, though non-genetic variables like sleep hygiene and work schedules exert a far greater influence. The association was primarily discovered in cohorts of European ancestry and may not display equivalent effects in other populations.
Carried by approximately 2% of individuals in European ancestry cohorts and rare in most non-European groups.
What Is rs62158206 and Where Is It Located?
The variant rs62158206 is a common single-nucleotide polymorphism (SNP) situated on chromosome 2 (2q14.1). In the human genome, it resides in an intergenic non-coding region upstream of the PAX8 gene and in close proximity to the long non-coding RNA gene PAX8-AS1. Because rs62158206 does not alter a protein-coding sequence directly, researchers hypothesize that it operates as a regulatory variant. It may influence the transcriptional activity, chromatin structure, or alternative splicing of nearby genes involved in development or metabolism. In large-scale genetic repositories like [dbSNP](https://www.ncbi.nlm.nih.gov/snp/rs62158206) and the [GWAS Catalog](https://www.ebi.ac.uk/gwas/variants/rs62158206), rs62158206 is cataloged as a common transition marker. It often tags a larger linkage disequilibrium block on chromosome 2 that consistently emerges in genetic scans of neurological, behavioral, and sleep architecture traits.
The Biological Role of the PAX8 Gene
The paired box gene 8 (PAX8) encodes a member of the paired box family of transcription factors. Historically recognized for its indispensable role during embryonic development, PAX8 directs the formation of the thyroid gland, urogenital organs, and parts of the nervous system. While traditional clinical genetics has focused on coding mutations in PAX8 causing congenital hypothyroidism, emerging genomics research suggests broader physiological roles. Endocrine balance, particularly thyroid hormone regulation, exerts a well-documented influence on metabolic rate, circadian pacing, and sleep-wake cycles. Additionally, recent epiallelic research has identified DNA methylation changes within PAX8 and its antisense counterpart, PAX8-AS1, that correlate with polysomnography-measured total sleep time. This highlights how regulatory variation in PAX8 may bridge endocrine pathways and central nervous system regulation of sleep.
Research Associations and Evidence Strength
Evidence linking the PAX8 region to sleep patterns is considered moderate to strong in epidemiological genetics, having been repeatedly replicated in cohorts such as the UK Biobank and the Million Veteran Program. In studies indexed in [PMC4975467](https://pmc.ncbi.nlm.nih.gov/articles/PMC4975467/) and [PMC10539313](https://pmc.ncbi.nlm.nih.gov/articles/PMC10539313/), rs62158206 emerged as a top genome-wide significant hit (often reaching p < 5 × 10⁻⁸) for usual sleep duration and categorical long sleep (nine hours or more per night). However, the absolute effect size is modest: each copy of the effect allele typically corresponds to an average shift of only two to three minutes of sleep per night. Like most complex behavioral traits, sleep duration is polygenic, shaped by thousands of minor genetic variants alongside lifestyle, environmental, and age-related variables.
Population Patterns and Ancestry Considerations
The minor allele of rs62158206 is relatively frequent in European-ancestry populations, with an estimated minor allele frequency of around 0.15. While large biobank studies primarily established its statistical significance within cohorts of European descent, multi-ancestry meta-analyses show more nuanced patterns. In some African-ancestry and East Asian cohorts, the variant exhibits differing allele frequencies, distinct linkage disequilibrium structures, or attenuated statistical significance. These ancestry-specific differences highlight that genetic markers identified in predominantly European cohorts cannot automatically be generalized across all populations without careful cross-ancestry validation.
Interpreting Your Genetic Data Responsibly
Learning your rs62158206 genotype provides an interesting glimpse into the polygenic nature of sleep physiology, but it is not a diagnostic test. Carrying one or two alleles associated with longer sleep duration does not cause hypersomnia, nor does it guarantee you will need extra rest each night. Sleep need is determined by complex interplays between homeostatic sleep pressure, circadian rhythm, psychological stress, work schedules, and sleep hygiene. This variant should never be used to diagnose a sleep disorder, alter medical treatment, or replace clinical evaluation. Anyone struggling with unrefreshing sleep, daytime sleepiness, or persistent insomnia should seek guidance from a qualified physician or accredited sleep specialist.
How common is this variant?
The minor allele frequency for rs62158206 is approximately 0.15 in populations of European ancestry, meaning about 25% to 30% of individuals carry at least one copy of the variant allele. Frequencies and linkage disequilibrium patterns vary across non-European cohorts, with weaker associations reported in East Asian and African groups.
Frequently asked questions
Does having rs62158206 mean I will sleep nine hours or more?
No. While rs62158206 is statistically linked to longer sleep duration in population studies, its actual individual effect is very small, accounting for only a few minutes per night. Lifestyle habits, work schedule, light exposure, and overall health have far greater control over how long you sleep.
Can rs62158206 diagnose a medical sleep disorder like hypersomnia or narcolepsy?
No, rs62158206 is a normal population trait polymorphism and cannot diagnose any clinical condition. Medical disorders that cause excessive daytime sleepiness or hypersomnia require comprehensive clinical assessment, including specialized tests such as nocturnal polysomnography and daytime multiple sleep latency tests.
Why would a thyroid-related gene like PAX8 influence my sleep?
PAX8 is a transcription factor critical for thyroid development and hormone pathways, which fundamentally regulate energy balance, body temperature, and metabolic rhythms. Researchers suspect that subtle regulatory changes affecting PAX8 or adjacent epigenetic regions could slightly modulate circadian pacing and neural wakefulness systems.
Can I use my rs62158206 result to change medications or supplements?
No. Genotype results for rs62158206 provide non-diagnostic recreational trait information and have no proven pharmacogenomic utility. You should never start, stop, or change any medication or supplement based on this result without direct medical supervision from your healthcare provider.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs62158206?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29